PTH holdings
Invesco Dorsey Wright Healthcare Momentum ETF
Positions
57 stored of 57 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | Not reported | Not reported | 20.795% | $48.9M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 2 | Invesco Private Government Fund | Not reported | Not reported | 6.835% | $16.1M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 3 | Guardant Health, Inc. | US40131M1099 | 40131M109 | 4.972% | $11.7M | Equity (common) | Corporate | United States | USD |
| 4 | Roivant Sciences Ltd. | BMG762791017 | G76279101 | 4.945% | $11.6M | Equity (common) | Corporate | Bermuda | USD |
| 5 | Revolution Medicines, Inc. | US76155X1000 | 76155X100 | 4.937% | $11.6M | Equity (common) | Corporate | United States | USD |
| 6 | Axsome Therapeutics, Inc. | US05464T1043 | 05464T104 | 4.123% | $9.7M | Equity (common) | Corporate | United States | USD |
| 7 | BrightSpring Health Services, Inc. | US10950A1060 | 10950A106 | 4.029% | $9.5M | Equity (common) | Corporate | United States | USD |
| 8 | Liquidia Corp. | US53635D2027 | 53635D202 | 3.012% | $7.1M | Equity (common) | Corporate | United States | USD |
| 9 | Erasca, Inc. | US29479A1088 | 29479A108 | 2.940% | $6.9M | Equity (common) | Corporate | United States | USD |
| 10 | Oruka Therapeutics, Inc. | US6876041087 | 687604108 | 2.737% | $6.4M | Equity (common) | Corporate | United States | USD |
| 11 | 10x Genomics, Inc. 10x Genomics, Inc., Class A | US88025U1097 | 88025U109 | 2.271% | $5.3M | Equity (common) | Corporate | United States | USD |
| 12 | Relay Therapeutics, Inc. | US75943R1023 | 75943R102 | 2.248% | $5.3M | Equity (common) | Corporate | United States | USD |
| 13 | Tango Therapeutics Inc. | US87583X1090 | 87583X109 | 2.157% | $5.1M | Equity (common) | Corporate | United States | USD |
| 14 | Travere Therapeutics, Inc. | US89422G1076 | 89422G107 | 2.156% | $5.1M | Equity (common) | Corporate | United States | USD |
| 15 | Oscar Health, Inc. Oscar Health, Inc., Class A | US6877931096 | 687793109 | 2.098% | $4.9M | Equity (common) | Corporate | United States | USD |
| 16 | Illumina, Inc. | US4523271090 | 452327109 | 2.081% | $4.9M | Equity (common) | Corporate | United States | USD |
| 17 | agilon health, Inc. | US00857U2069 | 00857U206 | 2.065% | $4.9M | Equity (common) | Corporate | United States | USD |
| 18 | Axogen, Inc. | US05463X1063 | 05463X106 | 2.058% | $4.8M | Equity (common) | Corporate | United States | USD |
| 19 | Arrowhead Pharmaceuticals, Inc. | US04280A1007 | 04280A100 | 2.015% | $4.7M | Equity (common) | Corporate | United States | USD |
| 20 | Spyre Therapeutics, Inc. | US00773J2024 | 00773J202 | 2.012% | $4.7M | Equity (common) | Corporate | United States | USD |
| 21 | Replimune Group, Inc. | US76029N1063 | 76029N106 | 1.929% | $4.5M | Equity (common) | Corporate | United States | USD |
| 22 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | G50871105 | 1.927% | $4.5M | Equity (common) | Corporate | Ireland | USD |
| 23 | Moderna, Inc. | US60770K1079 | 60770K107 | 1.896% | $4.5M | Equity (common) | Corporate | United States | USD |
| 24 | Cytokinetics, Inc. | US23282W6057 | 23282W605 | 1.888% | $4.4M | Equity (common) | Corporate | United States | USD |
| 25 | Viatris Inc. | US92556V1061 | 92556V106 | 1.821% | $4.3M | Equity (common) | Corporate | United States | USD |
| 26 | Centene Corp. | US15135B1017 | 15135B101 | 1.787% | $4.2M | Equity (common) | Corporate | United States | USD |
| 27 | Humana Inc. | US4448591028 | 444859102 | 1.769% | $4.2M | Equity (common) | Corporate | United States | USD |
| 28 | Ligand Pharmaceuticals Inc. | US53220K5048 | 53220K504 | 1.742% | $4.1M | Equity (common) | Corporate | United States | USD |
| 29 | Corcept Therapeutics Inc. | US2183521028 | 218352102 | 1.715% | $4.0M | Equity (common) | Corporate | United States | USD |
| 30 | Enliven Therapeutics, Inc. | US29337E1029 | 29337E102 | 1.698% | $4.0M | Equity (common) | Corporate | United States | USD |
| 31 | Twist Bioscience Corp. | US90184D1000 | 90184D100 | 1.590% | $3.7M | Equity (common) | Corporate | United States | USD |
| 32 | Hims & Hers Health, Inc. | US4330001060 | 433000106 | 1.573% | $3.7M | Equity (common) | Corporate | United States | USD |
| 33 | MBX Biosciences, Inc. | US55287L1017 | 55287L101 | 1.532% | $3.6M | Equity (common) | Corporate | United States | USD |
| 34 | Arcutis Biotherapeutics, Inc. | US03969K1088 | 03969K108 | 1.526% | $3.6M | Equity (common) | Corporate | United States | USD |
| 35 | Establishment Labs Holdings Inc. | VGG312491084 | G31249108 | 1.511% | $3.6M | Equity (common) | Corporate | British Virgin Islands | USD |
| 36 | uniQure N.V. | NL0010696654 | N90064101 | 1.503% | $3.5M | Equity (common) | Corporate | Netherlands | USD |
| 37 | PACS Group, Inc. | US69380Q1076 | 69380Q107 | 1.331% | $3.1M | Equity (common) | Corporate | United States | USD |
| 38 | Exelixis, Inc. | US30161Q1040 | 30161Q104 | 1.315% | $3.1M | Equity (common) | Corporate | United States | USD |
| 39 | Trevi Therapeutics, Inc. | US89532M1018 | 89532M101 | 1.169% | $2.7M | Equity (common) | Corporate | United States | USD |
| 40 | Krystal Biotech, Inc. | US5011471027 | 501147102 | 1.168% | $2.7M | Equity (common) | Corporate | United States | USD |
| 41 | National HealthCare Corp. | US6359061008 | 635906100 | 1.118% | $2.6M | Equity (common) | Corporate | United States | USD |
| 42 | Amneal Pharmaceuticals, Inc. | US03168L1052 | 03168L105 | 1.117% | $2.6M | Equity (common) | Corporate | United States | USD |
| 43 | Alkermes PLC | IE00B56GVS15 | G01767105 | 1.097% | $2.6M | Equity (common) | Corporate | Ireland | USD |
| 44 | Veracyte, Inc. | US92337F1075 | 92337F107 | 1.087% | $2.6M | Equity (common) | Corporate | United States | USD |
| 45 | NeoGenomics, Inc. | US64049M2098 | 64049M209 | 1.076% | $2.5M | Equity (common) | Corporate | United States | USD |
| 46 | Nuvation Bio Inc. | US67080N1019 | 67080N101 | 1.063% | $2.5M | Equity (common) | Corporate | United States | USD |
| 47 | TG Therapeutics, Inc. | US88322Q1085 | 88322Q108 | 1.055% | $2.5M | Equity (common) | Corporate | United States | USD |
| 48 | AbSci Corp. | US00091E1091 | 00091E109 | 0.994% | $2.3M | Equity (common) | Corporate | United States | USD |
| 49 | Denali Therapeutics Inc. | US24823R1059 | 24823R105 | 0.972% | $2.3M | Equity (common) | Corporate | United States | USD |
| 50 | Disc Medicine, Inc. | US2546041011 | 254604101 | 0.890% | $2.1M | Equity (common) | Corporate | United States | USD |
| 51 | AMN Healthcare Services, Inc. | US0017441017 | 001744101 | 0.817% | $1.9M | Equity (common) | Corporate | United States | USD |
| 52 | Guardian Pharmacy Services, Inc. Guardian Pharmacy Services, Inc., Class A | US40145W1018 | 40145W101 | 0.796% | $1.9M | Equity (common) | Corporate | United States | USD |
| 53 | Astrana Health, Inc. | US03763A2078 | 03763A207 | 0.727% | $1.7M | Equity (common) | Corporate | United States | USD |
| 54 | Clover Health Investments, Corp. | US18914F1030 | 18914F103 | 0.724% | $1.7M | Equity (common) | Corporate | United States | USD |
| 55 | Zevra Therapeutics, Inc. | US4884452065 | 488445206 | 0.643% | $1.5M | Equity (common) | Corporate | United States | USD |
| 56 | NovoCure Ltd. | JE00BYSS4X48 | G6674U108 | 0.616% | $1.4M | Equity (common) | Corporate | Jersey | USD |
| 57 | Invesco Government & Agency Portfolio Invesco Government & Agency Portfolio, Institutional Class | US8252528851 | 825252885 | 0.074% | $174K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |